Skip to content
Technische Universität Berlin Deutsch
Course catalog and module transfer system

Economics of the Pharmaceutical SectorModule description #70153 / Version 4

← Module page Deutsche Fassung
This module description is not valid in the current semester (Winter semester 2026/27).
Module / Version#70153 / #4
ValidityWinter semester 2020/21 – Winter semester 2021/22
Available language(s)German
Credit points6
Person responsible for the moduleHäussler, Bertram
GradingGraded
Exam formatPortfolio examination
Language(s) of instructionGerman

Affiliation

FacultyFakultät VII
InstituteInstitut für Volkswirtschaftslehre und Wirtschaftsrecht
Academic chair37311300 FG Ökonomie des öffentlichen Sektors, insbesondere Gesundheitsökonomie

Contact

OfficeH 80
Contact personBusse, Reinhard
E-mail addressmig@tu-berlin.de
Websitehttps://www.tu.berlin/mig/

Learning outcomes

Pharmaceuticals (drugs) are - at least in European Health Systems - often regarded as public goods. Therefore, the provision and usage of pharmaceuticals are uncoupled from the patients’ willingness to pay.
As a consequence, the realization of a steady stream of innovative medicinal products that often allow totally new ways to handle diseases, requires some form of market regulation. A distinctive feature of this market regulation (compared to the regulation of other network industries) is the fact that the national regulatory authorities have to regulate globally operating firms.
One of the most important regulatory measure that is currently being used is patent law. Patents create temporary monopolies. The idea is to establish sufficient economic incentives for pharmaceutical firms to invest in Research and Development (R&D): On the one hand, R&D in the pharmaceutical sector is a highly risky investment and requires substantial financial commitment, on the other hand - at least in many cases - imitation of successful innovations is quite easy. Thus, patents are necessary to allow innovators to profit from their investment previously made.
However, monopoly structures are welfare reducing through higher prices. Therefore, all industrialised countries have set up further regulatory mechanisms to cut or at least limit prices for drugs and expenses of the health insurance sector - and almost all countries have introduced different mechanims. Accordingly, a complex web of national regulatory systems has evolved that results in a permanent conflict situation between firms and regulatory authorities and between countries.
Despite these difficult legal conditions, the pharmaceutical industry is one of the most R&D-intense sectors and one of the most important knowledge-creating sectors. (Resulting, amongst others, in an international competition for the location of pharmaceutical firms.)
The intention of this module is first to understand competition and regulation in the pharmaceutical sector, which is in many points an extreme example in context of the industrialeconomic theory. Furthermore, solution will be discussed to optimize the different goals in the market. Second, alternative settings, regulation as well as competition policy, that aim to resolve the conflict between incentives to innovate and prevention of super-normal profits are discussed and assessed. The module relies on the basic knowledge of Industrial Economics and carve out its distinctive features in comparison to other markets.

Content

1. Market structure and economic relevance of the pharmaceutical industry
2. Expectation of society
3. Fundamental requirements of supply (technology) and demand (price elasticity)
4. Business model of the pharmaceutical industry
5. Market structure: Access and concentration
6. Characteristics of patents for pharmaceuticals
7. Regulation of the pharmaceutical industry in Germany and abroad
8. Methods for the clinical and economic assessment of drugs
9. Research processes
10. Product strategies
11. Pricing
12. Marketing and distribution
13. Cooperation and M&A
14. Outlook: Where does the industry go?

Module components

Compulsory area

The following courses are mandatory for this module:

CoursesTypeNumberFrequencyLanguageHours per weekCourse catalog
Ökonomik der pharmazeutischen IndustrieIntegrated course71 150 L 1628 Winter semester[de]4 ISIS

Workload and credit points

Ökonomik der pharmazeutischen Industrie (Integrated course)

Workload descriptionMultiplierHoursTotal
Homework and follow-up156 h90 h
Class attendance154 h60 h
Exam preparation130 h30 h
180 h

The workload of the module adds up to 180 hours. The module therefore comprises 6 credit points.

Description of teaching and learning methods

Integrierte Veranstaltung (IV)

Requirements for participation and examination

Desirable prerequisites for participation in the courses:

Basic knowledge of the health care system in Germany.
Module 70154 Industrial Economics passed.

Mandatory requirements for the module examination registration:

This module has no examination requirements.

Completion of the module

GradingGraded
Exam formatPortfolio examination
Type of portfolio examination100 points in total
LanguageGerman

Test elements

NamePoints/WeightCategoryDuration/Extent
Homework50writtenThe homework consists of 3 questions, 2 of which must be answered, question 1 mandatory.
Exam50written75 min

Exam description

The portfolio examination consists of the following elements, adding up to a maximum of 100 credits. The grading follows the joint conversion key of the School of Economics and Management (decision of the school's council dated May 28, 2014 - FKR VII-4/8-28.05.2014)

Duration of the module

The following number of semesters is estimated for taking and completing the module: 1 semester(s).

This module can be started in the following semesters: Winter semester.

Maximum number of participants

This module is not limited to a number of students.

Registration procedures

No registration is required.

Recommended reading, lecture notes

Lecture notes

unavailable

Electronic lecture notes

available – www.haeussler-tu-berlin.de

Recommended literature

  • Wird veröffentlicht auf www.haeussler-tu-berlin.de

Assigned programs

This module version is used in the following programs:

Program / program versionSemester(s)Curriculum component
Economics
StuPo 2018
WS 2020/21Compulsory Elective Modules › Specialisation Courses › Economic Specialisation Courses
SS 2021Compulsory Elective Modules › Specialisation Courses › Economic Specialisation Courses
WS 2021/22Compulsory Elective Modules › Specialisation Courses › Economic Specialisation Courses
Industrial Economics
StuPO 2018
WS 2020/21Compulsory Elective Modules › Field Courses › Field Courses
SS 2021Compulsory Elective Modules › Field Courses › Field Courses
WS 2021/22Compulsory Elective Modules › Field Courses › Field Courses
Industrial Engineering and Management
Industrial Engineering and Management (M. Sc.) - StuPO 2015
WS 2020/21Wirtschaftswissenschaften/Economic Sciences › Volkswirtschaftslehre/Economics (Wahlpflicht/Compulsory-Elective) › Health Economics
SS 2021Wirtschaftswissenschaften/Economic Sciences › Volkswirtschaftslehre/Economics (Wahlpflicht/Compulsory-Elective) › Health Economics
WS 2021/22Wirtschaftswissenschaften/Economic Sciences › Volkswirtschaftslehre/Economics (Wahlpflicht/Compulsory-Elective) › Health Economics

Miscellaneous

Not specified